More Lumos Diagnostics Holdings Ltd. news
Lumos Diagnostics Holdings Ltd.ASX: LDX

LDX received authorization to sell CoviDx in Canada

Nov 2, 2021 at 11:31 PM EDT · Issued by Lumos Diagnostics Holdings Ltd.

Filed with ASX · Nov 2, 2021 at 11:31 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/ldx-received-authorization-to-sell-covidx-in-canada

Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20↗

Lumos Diagnostics Holdings Ltd. on 6ix

Story so far

  • U.S FDA Deprioritises EUA Application for CoviDxSep 22, 2021

Earlier from Lumos Diagnostics

  • Monthly Activities/Appendix 4C Cash Flow ReportOct 26, 2021
  • Update on Economic Evaluation of FebriDxOct 7, 2021
  • Economic Evaluation of FebriDxOct 5, 2021
  • U.S FDA Deprioritises EUA Application for CoviDxSep 21, 2021
  • FY21 Full Year ResultsAug 30, 2021

Later from Lumos Diagnostics

  • Lumos Receives Initial Orders for CoviDx In CanadaDec 19, 2021
  • Lumos Provides ViraDx and FebriDx Regulatory UpdateDec 21, 2021
  • Over 100 Pharmacies in Liverpool UK Launch FebriDx ServiceJan 11, 2022
  • Victorian Government Intent for Lumos Manufacturing HubFeb 2, 2022
  • Change To Lumos BoardFeb 11, 2022
All Lumos Diagnostics news releases↗

Follow Lumos Diagnostics into a list and get an email when it puts out news.

Follow Lumos Diagnostics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer